Key result
AF in thyrotoxicosis is linked to a ~40% rate of thromboembolic episodes vs. sinus rhythm.
Why the study?
The incidence and clinical associations of atrial fibrillation and thromboembolic disease in patients with thyrotoxicosis were not well characterized.
Does atrial fibrillation increase the risk of thromboembolic episodes in patients with thyrotoxicosis?
Population
142 patients with thyrotoxicosis
Comparison
Patients with atrial fibrillation vs patients without atrial fibrillation
Design
Observational cohort study
Authors
Loading...
AF in thyrotoxicosis was associated with all thromboembolic events; hypothesis-generating for anticoagulation trials.
Observational (n=142)
Does atrial fibrillation increase the risk of thromboembolic episodes in patients with thyrotoxicosis?
Absolute Event Rate: 40% vs 0%
Thyrotoxicosis patients with atrial fibrillation have a high rate of thromboembolic episodes (40%), supporting the use of anticoagulation in this population.
Shlomo Bar-Sela (1981) conducted an observational in Thyrotoxicosis (n=142). Atrial fibrillation vs. No atrial fibrillation was evaluated on Thromboembolic episodes. Atrial fibrillation in patients with thyrotoxicosis was associated with thromboembolic episodes, occurring in 40% of patients with AF compared to 0% of those without AF.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: